US Bancorp’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$93.7K Buy
2,973
+1,409
+90% +$40.6K ﹤0.01% 2423
2025
Q4
$38.8K Sell
1,564
-728
-32% -$14.6K ﹤0.01% 2807
2025
Q3
$37.2K Buy
2,292
+283
+14% +$4.01K ﹤0.01% 2800
2025
Q2
$26.3K Sell
2,009
-1,204
-37% -$17.4K ﹤0.01% 3068
2025
Q1
$70.7K Sell
3,213
-96
-3% -$2.52K ﹤0.01% 2568
2024
Q4
$88.3K Sell
3,309
-5,227
-61% -$166K ﹤0.01% 2454
2024
Q3
$228K Buy
8,536
+8,468
+12,453% +$168K ﹤0.01% 1970
2024
Q2
$1.23K Hold
68
﹤0.01% 3782
2024
Q1
$1.24K Buy
+68
New +$1.08K ﹤0.01% 3795
2023
Q4
Sell
-180
Closed -$1.03K 4038
2023
Q3
$1.03K Sell
180
-304
-63% -$2.07K ﹤0.01% 3761
2023
Q2
$3.75K Buy
+484
New +$4.08K ﹤0.01% 3555
2023
Q1
Sell
-236
Closed -$2.11K 4119
2022
Q4
$2.11K Buy
+236
New +$2.21K ﹤0.01% 3759

Other funds holding EWTX